Antimicrobial Agents Practice Questions

Q: Which anti-tubercular drug combination is safer in a patient who develops hepatitis while on ATT?

Streptomycin + Ethambutol. **Explanation:** The primary concern when managing a patient who develops drug-induced hepatitis during Anti-Tubercular Therapy (ATT) is to avoid further hepatotoxicity. **1. Why Streptomycin + Ethambutol is correct:** Among the first-line ATT drugs, **Isoniazid (H), Rifampicin (R), and Pyrazinamide (Z)** are known to be hepatotoxic [1]. In contrast, **Ethambutol (E) and Streptomycin (S)** are non-hepatotoxic drugs. When a patient develops clinical jaundice or a significant rise in liver enzymes (ALT/AST >3x with symptoms or >5x without symptoms), all hepatotoxic drugs must be stopped immediately. A safe "non-hepatotoxic" regimen consisting of Streptomycin and Ethambutol is initiated until the liver functions normalize. **2. Why the other options are incorrect:** * **Options A & C:** Both contain **Isoniazid (H)**, which is a potent hepatotoxin (via its metabolic pathway) [1]. * **Option D:** Contains **Rifampicin (R)**, which can cause cholestatic jaundice and potentiate the toxicity of other drugs [1]. Since these options contain at least one hepatotoxic agent, they are unsafe during the acute phase of hepatitis. **Clinical Pearls for NEET-PG:** * **Hepatotoxicity Order:** The most hepatotoxic drug is **Pyrazinamide**, followed by **Isoniazid**, and then **Rifampicin** (Z > H > R) [1]. * **Management Protocol:** Once the AST/ALT levels return to <2x the upper limit of normal, hepatotoxic drugs are reintroduced one by one (usually Rifampicin first, then Isoniazid, then Pyrazinamide). * **Safe in Liver Disease:** Streptomycin, Ethambutol, and Fluoroquinolones (like Levofloxacin) are the preferred agents when the standard HRZE regimen cannot be used due to liver dysfunction [1].

Q: Which of the following drugs acts by inhibiting bacterial protein synthesis?

Streptomycin. **Explanation:** The correct answer is **Streptomycin**. Streptomycin is an **Aminoglycoside** antibiotic that acts by binding to the **30S ribosomal subunit** of bacteria. This binding causes misreading of the mRNA code and inhibits the initiation of protein synthesis, leading to a bactericidal effect. **Analysis of Options:** * **A. Bacitracin:** This drug inhibits **cell wall synthesis** by interfering with the dephosphorylation of the lipid carrier (bactoprenol) that transports peptidoglycan precursors across the cell membrane. * **B. Dapsone:** This is a sulfonamide-like drug used in leprosy. It inhibits the enzyme **dihydropteroate synthase**, thereby blocking **folic acid synthesis**. * **C. Ethambutol:** An antitubercular drug that inhibits **arabinosyltransferase**, an enzyme essential for the synthesis of **arabinogalactan** in the mycobacterial cell wall. **High-Yield Clinical Pearls for NEET-PG:** * **Protein Synthesis Inhibitors Mnemonic:** * **30S inhibitors:** **A**minoglycosides (Streptomycin, Gentamicin), **T**etracyclines (**"AT 30"**). * **50S inhibitors:** **C**hloramphenicol, **E**rythromycin (Macrolides), **L**inezolid, **L**incosamides (Clindamycin) (**"CELL at 50"**). * **Streptomycin Specifics:** It is the only aminoglycoside used as a first-line drug for Tuberculosis (though now often replaced by oral regimens). Its major side effects are **ototoxicity** (vestibular damage) and **nephrotoxicity**. * **Ethambutol** is unique among first-line ATT for causing **optic neuritis** (red-green color blindness).

Q: All of the following are bactericidal except?

Oxytetracycline. ### Explanation The classification of antibiotics into **bactericidal** (kill bacteria) and **bacteriostatic** (inhibit growth) is a high-yield concept for NEET-PG. **1. Why Oxytetracycline is the correct answer:** Oxytetracycline belongs to the **Tetracycline** class. These agents act by reversibly binding to the **30S ribosomal subunit**, inhibiting protein synthesis. Because the binding is reversible and only halts the multiplication of bacteria without immediate cell death, they are classified as **bacteriostatic**. **2. Why the other options are incorrect:** * **Cephalexin (Option A):** This is a first-generation cephalosporin. Like all beta-lactams, it inhibits cell wall synthesis by binding to Penicillin-Binding Proteins (PBPs), leading to cell lysis. It is **bactericidal**. * **Rifampicin (Option B):** It inhibits DNA-dependent RNA polymerase. By blocking the transcription of essential RNA, it causes rapid bacterial death. It is a potent **bactericidal** drug. * **Isoniazid (Option C):** It inhibits the synthesis of mycolic acids, essential components of the mycobacterial cell wall. It is **bactericidal** against rapidly dividing *M. tuberculosis* (though it can be bacteriostatic against resting organisms). **3. Clinical Pearls & High-Yield Facts:** * **Mnemonic for Bactericidal drugs:** "**V**ery **F**inely **P**roficient **A**t **C**ell **M**urder" (**V**ancomycin, **F**luoroquinolones, **P**enicillins/Beta-lactams, **A**minoglycosides, **C**otrimoxazole, **M**etronidazole). * **Exception:** Aminoglycosides are the only major class of protein synthesis inhibitors that are **bactericidal** (irreversible binding). * **Antagonism:** Generally, bacteriostatic drugs (like Tetracyclines) should not be combined with bactericidal drugs (like Penicillins) because bactericidal drugs require the bacteria to be actively dividing to be effective.

Q: A 25-year-old male hospitalized with a liver cyst due to Echinococcus granulosis refused surgery. Albendazole was administered at a high dose for 3 months. For which organ's toxicity should this patient be monitored?

Liver. **Explanation:** The correct answer is **Liver (Option C)**. **Underlying Medical Concept:** Albendazole is a benzimidazole carbamate used as the drug of choice for Hydatid disease (*Echinococcus granulosus*). While it is generally well-tolerated for short-term use (e.g., 1–3 days for intestinal worms), **prolonged high-dose therapy** required for systemic infections like liver cysts necessitates strict monitoring. Albendazole is extensively metabolized in the liver to its active metabolite, albendazole sulfoxide. Long-term administration is frequently associated with a transient rise in serum transaminases (ALT/AST) and, in some cases, severe hepatotoxicity or jaundice. Therefore, Liver Function Tests (LFTs) must be monitored at the start of each treatment cycle and every two weeks during therapy. **Analysis of Incorrect Options:** * **A. Gonads:** While some benzimidazoles showed teratogenic potential in animal studies (hence avoided in pregnancy), they are not typically associated with gonadal toxicity or infertility in humans. * **B. Kidney:** Albendazole is primarily eliminated via biliary excretion; renal impairment is not a common side effect, and routine monitoring of renal function is not mandatory for this drug. * **D. Peripheral nerves:** Neurotoxicity is not a recognized side effect of albendazole. Peripheral neuropathy is more commonly associated with drugs like Isoniazid, Ethambutol, or Vincristine. **High-Yield NEET-PG Pearls:** * **Mechanism of Action:** Inhibits microtubule synthesis by binding to **β-tubulin**, leading to glucose depletion and death of the parasite. * **Monitoring:** Besides LFTs, **Complete Blood Counts (CBC)** should be monitored due to the risk of bone marrow suppression (leukopenia/pancytopenia) during long-term use. * **Absorption:** Oral absorption is significantly **increased with a fatty meal** (crucial for systemic infections like Hydatid disease or Neurocysticercosis).

Q: Cross-resistance to macrolides occurs primarily due to which of the following mechanisms?

Methylation of the 50S ribosome. ### Explanation **1. Why Option C is Correct:** The most common and clinically significant mechanism of resistance to macrolides (like Erythromycin and Azithromycin) is **ribosomal protection**. This occurs via the production of an enzyme called **methylase**, encoded by the **_erm_ gene** (Erythromycin Ribosome Methylation). This enzyme methylates a specific adenine residue on the **23S rRNA** of the **50S ribosomal subunit**. This structural modification reduces the binding affinity of the drug to its target site. Because Macrolides, Lincosamides (Clindamycin), and Streptogramin B share overlapping binding sites, this mechanism leads to **cross-resistance** among all three classes, a phenomenon known as **MLS_B resistance**. **2. Why Other Options are Incorrect:** * **Option A (Efflux Pump):** While efflux pumps (encoded by the _mef_ gene) do exist and contribute to resistance (especially in *S. pneumoniae*), they typically result in lower levels of resistance and do not usually cause the broad cross-resistance seen with ribosomal methylation. * **Option B (Hydrolyzing Enzymes):** Enzymatic inactivation (e.g., by esterases) is a rare mechanism of resistance for macrolides, primarily seen in certain Gram-negative bacteria like *Enterobacteriaceae*, but it is not the primary cause of cross-resistance. **3. NEET-PG High-Yield Pearls:** * **MLS_B Phenotype:** If a lab report shows resistance to Erythromycin, always check for Clindamycin resistance (the **D-test** is used to detect inducible Clindamycin resistance). * **Mechanism of Action:** Macrolides are bacteriostatic; they inhibit protein synthesis by binding to the 50S subunit and preventing **translocation**. * **Drug of Choice:** Macrolides are the preferred alternative for Penicillin-allergic patients with Streptococcal infections and are the first-line treatment for **Atypical Pneumonia** (*Mycoplasma, Legionella*).

Q: A patient on indinavir treatment presents with jaundice. Detailed evaluation reveals that the elevated bilirubin is mainly the indirect fraction. What is the probable mechanism of indirect hyperbilirubinemia in this setting?

Decreased conjugation. ### Explanation **Correct Option: C. Decreased conjugation** Indinavir, a Protease Inhibitor (PI) used in HIV treatment, is well-known to cause asymptomatic **indirect (unconjugated) hyperbilirubinemia**. The underlying mechanism is the **potent inhibition of Uridine diphosphate-glucuronosyltransferase (UGT1A1)**, the enzyme responsible for conjugating bilirubin in the liver. This mimics the clinical presentation of **Gilbert Syndrome**. Since the bilirubin cannot be conjugated, it remains in the indirect form, leading to jaundice without significant elevation of transaminases or alkaline phosphatase. **Analysis of Incorrect Options:** * **A. Increased bilirubin production:** This typically occurs in states of massive cell turnover or ineffective erythropoiesis, which is not the mechanism for indinavir-induced jaundice. * **B. Decreased hepatocellular uptake:** While some drugs (like Rifampicin) can interfere with the uptake of bilirubin into hepatocytes via OATP transporters, Indinavir specifically targets the enzymatic conjugation step. * **D. Hemolysis:** Although hemolysis causes indirect hyperbilirubinemia, Indinavir does not typically cause red cell breakdown. In hemolysis, you would also expect low haptoglobin and elevated LDH, which are absent here. **High-Yield Clinical Pearls for NEET-PG:** * **Indinavir Side Effects:** Remember the triad: **Indirect Hyperbilirubinemia**, **Nephrolithiasis** (crystalluria—patients must stay hydrated), and **Lipodystrophy** (buffalo hump/insulin resistance). * **Atazanavir:** Another Protease Inhibitor that frequently causes indirect hyperbilirubinemia via the same UGT1A1 inhibition mechanism. * **Gilbert Syndrome Link:** Patients with pre-existing Gilbert Syndrome are at a much higher risk of developing visible jaundice when started on Indinavir or Atazanavir.

Q: Which of the following drugs, when administered in high doses, can cause convulsions?

Penicillin. **Explanation:** **1. Why Penicillin is the Correct Answer:** High doses of Penicillins, particularly **Penicillin G**, are well-known to be neurotoxic. The underlying mechanism is the **antagonism of GABA-A receptors** in the central nervous system. Since GABA is the primary inhibitory neurotransmitter, its blockade leads to neuronal hyperexcitability, which can manifest as myoclonus or generalized tonic-clonic **convulsions**. This risk is significantly increased in patients with **renal failure** (due to drug accumulation) or those with pre-existing seizure disorders. **2. Why Other Options are Incorrect:** * **Aminoglycosides (e.g., Gentamicin):** These are primarily associated with **ototoxicity** (vestibular and cochlear damage) and **nephrotoxicity** (acute tubular necrosis). They do not typically cause CNS excitation or seizures. * **Erythromycin (Macrolide):** The hallmark adverse effects of Macrolides include GI upset, **cholestatic jaundice** (especially with Erythromycin estolate), and **QT interval prolongation**. They are not associated with convulsions. **3. High-Yield Clinical Pearls for NEET-PG:** * **Other Antibiotics causing Seizures:** Apart from Penicillins, **Imipenem** (a Carbapenem) and **Fluoroquinolones** (e.g., Ciprofloxacin) are high-yield causes of drug-induced seizures. * **Imipenem vs. Meropenem:** Imipenem has a higher seizure potential than Meropenem; hence Meropenem is preferred in CNS infections like meningitis. * **Ceftriaxone:** While most Beta-lactams can cause seizures at very high doses, Ceftriaxone is more commonly noted for causing **biliary sludge** (pseudolithiasis). * **Management:** Drug-induced seizures are generally managed by discontinuing the offending agent and administering **Benzodiazepines**.

Q: Which of the following statements about terbinafine is FALSE?

It is used topically only.. **Explanation:** Terbinafine is an **allylamine** antifungal agent that plays a crucial role in treating superficial fungal infections. **1. Why Option D is the Correct Answer (The False Statement):** Terbinafine is **not** used topically only. It has excellent oral bioavailability and is highly lipophilic and keratophilic. When taken orally, it accumulates in high concentrations in the skin, sebum, and nails. This makes **oral terbinafine** the drug of choice for systemic treatment of fungal nail infections (onychomycosis) and extensive tinea corporis. **2. Analysis of Incorrect Options:** * **Option A (Restricted to dermatophytes):** While terbinafine has some activity against *Candida*, its clinical efficacy is primarily and significantly superior against **dermatophytes** (e.g., *Trichophyton*, *Epidermophyton*, and *Microsporum*). * **Option B (Effective in onychomycosis):** Due to its keratophilic nature, it remains in the nail plate for weeks even after stopping therapy. It is considered more effective than griseofulvin or itraconazole for fungal nail infections. * **Option C (Inhibits squalene epoxidase):** This is its primary mechanism of action. By inhibiting this enzyme, it prevents the conversion of squalene to lanosterol. This leads to a **deficiency of ergosterol** (essential for fungal cell membranes) and a **toxic accumulation of squalene**, which is fungicidal. **Clinical Pearls for NEET-PG:** * **Mechanism:** Inhibits Squalene Epoxidase (unlike Azoles, which inhibit 14-α demethylase). * **Nature:** It is **fungicidal** against dermatophytes (Azoles are mostly fungistatic). * **Side Effects:** Most common are GI upset and taste disturbances. Rarely, it can cause hepatotoxicity (monitor LFTs). * **Drug of Choice:** Oral terbinafine is the gold standard for **Onychomycosis**.

Q: All of the following drugs have activity against hepatitis EXCEPT:

Zidovudine. **Explanation:** The core concept tested here is the specificity of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) for different viral polymerases. While many NRTIs are used for both HIV and Hepatitis B (HBV), **Zidovudine (AZT)** is exclusively an anti-retroviral agent with no clinical activity against the Hepatitis B virus. **1. Why Zidovudine is the correct answer:** Zidovudine was the first NRTI approved for HIV. It specifically inhibits the HIV reverse transcriptase enzyme. Unlike other drugs in its class, it does not effectively inhibit the HBV DNA polymerase. Therefore, it has no role in the treatment of any form of viral hepatitis. **2. Why the other options are incorrect:** * **Lamivudine (3TC):** A potent inhibitor of both HIV reverse transcriptase and HBV DNA polymerase. It was the first oral antiviral approved for Chronic Hepatitis B. * **Emtricitabine (FTC):** Structurally related to Lamivudine, it is highly effective against both HIV and HBV. It is frequently used in co-infected patients. * **Telbivudine:** An L-thymidine nucleoside analogue specifically indicated for the treatment of Chronic Hepatitis B. It is not used for HIV. **High-Yield Clinical Pearls for NEET-PG:** * **HBV + HIV Co-infection:** Drugs active against both include **Tenofovir (TDF/TAF)**, **Lamivudine**, and **Emtricitabine**. Tenofovir is currently the preferred backbone for co-infection. * **Entecavir:** A potent anti-HBV drug that should *not* be used as monotherapy in HIV-infected patients because it can select for the M184V mutation in HIV. * **Zidovudine Side Effects:** Remember the "3 Ms": **M**acrocytic anemia (bone marrow suppression), **M**yopathy, and **M**elanonychia (nail pigmentation).

Question 1

Which anti-tubercular drug combination is safer in a patient who develops hepatitis while on ATT?

Accepted Answer

Streptomycin + Ethambutol

Answer

Streptomycin + Isoniazid

Answer

Ethambutol + Isoniazid

Answer

Ethambutol + Rifampicin

Question 2

Which of the following drugs acts by inhibiting bacterial protein synthesis?

Accepted Answer

Streptomycin

Answer

Bacitracin

Answer

Dapsone

Answer

Ethambutol

Question 3

All of the following are bactericidal except?

Accepted Answer

Oxytetracycline

Answer

Cephalexin

Answer

Rifampicin

Answer

Isoniazid

Question 4

A 25-year-old male hospitalized with a liver cyst due to Echinococcus granulosis refused surgery. Albendazole was administered at a high dose for 3 months. For which organ's toxicity should this patient be monitored?

Accepted Answer

Liver

Answer

Gonads

Answer

Kidney

Answer

Peripheral nerves

Question 5

Cross-resistance to macrolides occurs primarily due to which of the following mechanisms?

Accepted Answer

Methylation of the 50S ribosome

Answer

Efflux of drug out of the cell by a pump

Answer

Induction of an enzyme that hydrolyzes macrolides

Answer

None of the above

Question 6

The Eagle effect is observed in which of the following microorganisms?

Accepted Answer

Enterococcus faecalis

Answer

Staphylococcus aureus

Answer

Pseudomonas aeruginosa

Answer

Streptococcus pyogenes

Question 7

A patient on indinavir treatment presents with jaundice. Detailed evaluation reveals that the elevated bilirubin is mainly the indirect fraction. What is the probable mechanism of indirect hyperbilirubinemia in this setting?

Accepted Answer

Decreased conjugation

Answer

Increased bilirubin production

Answer

Decreased hepatocellular uptake

Answer

Hemolysis

Question 8

Which of the following drugs, when administered in high doses, can cause convulsions?

Accepted Answer

Penicillin

Answer

Aminoglycosides

Answer

Erythromycin

Answer

All of the above

Question 9

Which of the following statements about terbinafine is FALSE?

Accepted Answer

It is used topically only.

Answer

Its activity is restricted to dermatophytes.

Answer

It is effective in onychomycosis.

Answer

It inhibits squalene epoxidase.

Question 10

All of the following drugs have activity against hepatitis EXCEPT:

Accepted Answer

Zidovudine

Answer

Lamivudine

Answer

Emtricitabine

Answer

Telbivudine

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?